QCM
OCUL icon

Quantinno Capital Management’s Ocular Therapeutix OCUL Stock Holding History

Quantinno Capital Management’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$98.4K Buy
+11,612
New +$111K ﹤0.01% 3261
2025
Q2 		– Sell
-11,079
Closed -$81.2K – 2617
2025
Q1 		$81.2K Buy
+11,079
New +$85.1K ﹤0.01% 2062

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Quantinno Capital Management's OCUL Position: Q1 2026 in Review

Quantinno Capital Management opened a new position in Ocular Therapeutix (OCUL) in Q1 2026: 11,612 shares worth $98.4K. The stake represents ﹤0.01% of the portfolio and ranks #3261 among its holdings. This is a return to the name: Quantinno Capital Management previously reported a position in OCUL as recently as Q1 2025.

Quantinno Capital Management first reported a position in OCUL in Q1 2025 and has held it in 2 quarters since. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • Quantinno Capital Management held 11,612 shares of Ocular Therapeutix worth $98.4K as of Q1 2026.
  • Ocular Therapeutix was a new Quantinno Capital Management position in Q1 2026.
  • Ocular Therapeutix made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #3261 holding.
  • Quantinno Capital Management first reported a position in Ocular Therapeutix in Q1 2025 and has held it in 2 quarters since.
  • 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.